Table 2.
Probiotic-based therapy for prevention of peri-implantitis and peri-mucositis process
| Probiotic composition | Efficacy | References |
|---|---|---|
| Lactobacillus species |
•Inhibit the pathogenic bacteria S. mutans, A. actinomycetemcomitans, P. gingivalis and P. intermedia; •Strongest antimicrobial activity was associated with L. paracasei, L. plantarum, L. rhamnosus and L. salivarius |
[60] |
| L. reuteri |
•Slight decreasing of peri-implantitis rate; •Reduction of periodontal and peri-implantitis related species, as P. gingivalis; •Prevention of inflammation, reducing mucositis process; •Clinically effective in terms of pocket depth reduction in this peri-implantitis treatment, but without reaching baseline levels |
[59–64] |
| S. salivarius |
•Bacteriocin produced by S. salivarius inhibit the quorum-sensing signals and reducing the S. intermedius biofilm formation in titanium implant surface; •May be ineffective in peri‐implant disease treatment, when caused by C. albicans pathogen |
[65, 66] |